David Nierengarten

Stock Analyst at Wedbush

(3.72)
# 757
Out of 4,984 analysts
200
Total ratings
46.34%
Success rate
8.91%
Average return

Stocks Rated by David Nierengarten

Nuvation Bio
Sep 8, 2025
Reiterates: Outperform
Price Target: $6
Current: $3.24
Upside: +85.19%
Nuvalent
Sep 8, 2025
Reiterates: Outperform
Price Target: $115
Current: $79.92
Upside: +43.89%
Shattuck Labs
Sep 8, 2025
Initiates: Outperform
Price Target: $4
Current: $2.05
Upside: +94.99%
Xencor
Sep 2, 2025
Reiterates: Outperform
Price Target: $26
Current: $9.75
Upside: +166.67%
Telix Pharmaceuticals
Aug 28, 2025
Reiterates: Outperform
Price Target: $22
Current: $9.26
Upside: +137.58%
BridgeBio Oncology Therapeutics
Aug 18, 2025
Initiates: Outperform
Price Target: $25
Current: $12.00
Upside: +108.33%
Generation Bio Co.
Aug 13, 2025
Downgrades: Neutral
Price Target: $7
Current: $5.85
Upside: +19.76%
Vor Biopharma
Jun 26, 2025
Reiterates: Neutral
Price Target: $0.4
Current: $1.48
Upside: -72.88%
argenx SE
Jun 24, 2025
Reiterates: Outperform
Price Target: $715
Current: $730.06
Upside: -2.06%
Perspective Therapeutics
Jun 23, 2025
Reiterates: Outperform
Price Target: $11
Current: $3.26
Upside: +237.42%
Reiterates: Neutral
Price Target: $10
Current: $14.66
Upside: -31.79%
Maintains: Neutral
Price Target: $29$27
Current: $12.87
Upside: +109.79%
Reiterates: Outperform
Price Target: $34
Current: $35.59
Upside: -4.47%
Reiterates: Outperform
Price Target: $33
Current: $9.29
Upside: +255.22%
Downgrades: Neutral
Price Target: $8$2
Current: $0.86
Upside: +132.21%
Reiterates: Neutral
Price Target: $5
Current: $1.00
Upside: +400.00%
Reiterates: Outperform
Price Target: $31
Current: $11.00
Upside: +181.82%
Maintains: Outperform
Price Target: $40
Current: $20.39
Upside: +96.17%
Maintains: Outperform
Price Target: $87$90
Current: $38.20
Upside: +135.60%
Maintains: Outperform
Price Target: $40$47
Current: $31.50
Upside: +49.21%
Reiterates: Outperform
Price Target: $20
Current: $10.81
Upside: +85.01%
Initiates: Outperform
Price Target: $40
Current: $16.16
Upside: +147.52%
Initiates: Outperform
Price Target: $45
Current: $15.22
Upside: +195.66%
Reiterates: Outperform
Price Target: $10
Current: $1.64
Upside: +509.76%
Initiates: Outperform
Price Target: $18
Current: $2.34
Upside: +669.23%
Reiterates: Outperform
Price Target: $57
Current: $61.26
Upside: -6.95%
Reiterates: Neutral
Price Target: $10
Current: $12.41
Upside: -19.42%
Reiterates: Outperform
Price Target: $12
Current: $5.14
Upside: +133.46%
Reiterates: Outperform
Price Target: $57
Current: $24.32
Upside: +134.38%
Upgrades: Outperform
Price Target: $50$175
Current: $7.35
Upside: +2,280.95%
Maintains: Equal-Weight
Price Target: $1,400$500
Current: $3.73
Upside: +13,304.83%
Maintains: Neutral
Price Target: $105$60
Current: $6.06
Upside: +890.10%
Maintains: Outperform
Price Target: $11$19
Current: $8.79
Upside: +116.15%
Maintains: Outperform
Price Target: $71$75
Current: $28.76
Upside: +160.78%
Downgrades: Neutral
Price Target: n/a
Current: $1.14
Upside: -
Upgrades: Outperform
Price Target: n/a
Current: $4.38
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $8.16
Upside: -